Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Delafloxacin

An antibiotic of the fluoroquinolone family, approved in the United States in 2017 for acute bacterial skin and skin structure infections and later also for community-acquired pneumonia; in Europe since 2019. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Unlike most fluoroquinolones it is anionic: in acidic environments, such as many infection sites, it accumulates up to ten times more in bacteria and cells.

DelafloxacinGo to the active ingredient →
DelafloxacinActive ingredientDelafloxacinCat. No. P-D036-001CAS 189279-58-1

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.